|
Dr.
Christopher Hall's
Summer Project
|
 
Wild
mammals as sylvatic reservoirs of Trypanosoma cruzi.
Trypanosoma cruzi is the etiological agent for
Chagas' disease, being vectored by members of the
blood-feeding reduviid family of arthropods. The insect's
habit of feeding upon the face, particularly around the
mouth, has earned these insects the common name
"Kissing Bugs". T. cruzi currently
infects approximately 20 million people, and The World
Health Organization currently lists Chagas' disease in its
list of top ten tropical diseases for increased research.
They specifically suggest that new research targeting
sylvatic vector and reservoir populations would yield the
greatest benefits to scientific and health. While commonly
associated with the Lower Americas, T. cruzi and
its vectors are widely distributed across southern North
America. Numerous wild and domestic mammals serve as
sylvatic reservoirs for the parasite, with prevalence
rates reaching 60% in some regions. Although opportunities
for human infection must certainly occur, there have been
only limited descriptions of autochthonous infections in
man, despite evidence that primate species are susceptible
to regional parasite strains. Although one reason for the
low prevalence rate among the human population is believed
to involve differences in vector feeding behavior and
quality of housing, no data has been offered to support
the theory. We propose to experimentally explore the
behavior of the regional vector species, Triatoma
sanguisuga, and compare it to other vector species
associated with transmission in T. cruzi in humans.
We will also continue to conduct surveys of sylvatic
reservoir hosts to establish relative prevalence in
raccoons and opossums. In addition, experimental
infections will be carried out in mice to measure the
virulence and transmission of regional isolates and
compare them to those in Latin America. NSF-REU students would be involved in the
design and conduction of feeding trials, maintenance of
experimental T. sanguisuga cultures, immunological
assays, data analysis, and presentation/publication
activities.
|